Acute Pulmonary Embolism in Argentina. XX CONAREC Registry

Ignacio Cigalini, Dario Ben Igolnikof, Cristhian E. Scatularo, Juan C. Jauregui, Maico I. Bernal, Sebastián García Zamora, José M. Bonorino, Jorge Thierer, Ezequiel J. Zaidel


Background: Acute pulmonary embolism (PE) represents the third cause of cardiovascular mortality. However, there is lackof information about this entity in our country. Our aim was to describe baseline characteristics, clinical evolution and treatmentof patients with acute PE in Argentina.Methods: This was a prospective multicenter registry including patients with acute PE hospitalized in centers with cardiologyresidency from October 2016 to November 2017. Conventional analysis was performed for descriptive and comparativestatistics. A value of p<0.05 was considered significant. Cross audit was performed to 20% of participating centers.Results: We included 684 consecutive patients from 75 centers with an average age of 63.8 years and 388 (57%) women. Hospitaladmission was due to PE in 484 (71%) cases. The most frequent predisposing factors were obesity, recent hospitalization,transient rest and active cancer. Anticoagulation was indicated in 661 patients (97%) and reperfusion therapy was performedin 91 (13%). However, only 50 of the 102 patients who presented with hemodynamic instability received reperfusion therapy(49%). Global in-hospital mortality was 12%, mainly associated with acute PE (51%).Conclusions: Acute pulmonary embolism presents with high in-hospital mortality in our setting, mainly related to the embolicevent. We observed a low use of reperfusion therapies in patients with hemodynamic instability.


Heit J. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol 2008;28:370-2. http://

Horlander KT MDLK. Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Arch Intern Med 2003;163:1711-7.

Arya R. Venous Thromboembolism Prevention. A Patient Safety Priority. London: Department of Health; 2009.

Cohen A, Agnelli G, Anderson F, Arcelus J, Bergqvist D, Brecht J, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007;98:756-64.

The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. U.S. Department of Health and Human Services; 2008.

Pollack C, Schreiber D, Goldhaber S, Slattery D, Fanikos J, O’Neil B, et al. Clinical characteristics, management, and outcomes of pa¬tients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). J Am Coll Cardiol 2011;57:700-6.

Laporte S, Mismetti P, De´cousus H, Uresandi F, Otero R, Lobo J, et al. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad Trombo Embólica venosa (RIETE) Registry. Circulation 2008;117:1711-6.

Goldhaber S, Visani L, De Rosa M. Acute pulmonary embolism: clin¬ical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999;117:1386-9.

Kasper W, Konstantinides S, Geibel A. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 1997;30:1165-71.

Castillo Costa Y, Gómez Santa María H, Mauro V, Blanco Cerdeira P, Thierer J, Higa C. Registro Argentino de Enfermedad Tromboem¬bólica Venosa. Rev Argent Cardiol 2013;81:251-7.

Kostantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galie N, et al. 2014 ESC Guidelines on the diagnosis and manage¬ment of acute pulmonary embolism. Eur Heart J 2014;35:3033-80.

Aujesky D, Obrosky D, RA S, Auble T, Perrier A, Cornuz J, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005;172:1041-6. http://doi. org/dvpgd2

Donzé J, Le Gal G, Fine M, Roy P, Sanchez O, Verschuren F, et al. Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism. Thromb Haemost 2008;100:943-8.

Jiménez D, Aujesky D, Moores L, Gómez V, Lobo J, Uresandi F, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010;170:1383-9.

Ruíz-Giménez N, Suárez C, González R, Nieto J, Todolí J, Samperiz A, et al. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Find¬ings from the RIETE Registry. Thromb Haemost 2008;100:26-31.

Kooiman J, van Hagen N, Iglesias del Sol A, Planken E, Lip G, van der Meer F, et al. The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treat¬ment. PLoS One 2015;10:e0122520.

Mehran R, Rao S, Bhatt D, Gibson C, Caixeta A, Eikelboom J, et al. Standardized Bleeding Definitions for Cardiovascular Clinical Trials. A Consensus Report From the Bleeding Academic Research Consortium. Circulation 2011;123:2736-47.

Cigalini I, Igolnikof D, Jauregui J, Ortego J, Aboy J, Cornejo D, Scatularo C, et al. Tromboembolismo de Pulmón en la República Argentina. Registro CONAREC XX: Protocolo. Revista Conarec. 2018;33:244-5

Agnelli G, Verso M, Ageno W, Imberti D, Moia M, Palareti G, et al. The MASTER registry on venous thromboembolism: Description of the study cohort. Thrombosis Research 2008;121: 605-10. http://

Dennis R, Rojas M, Molina A, Roa J, Granados M, Londoño A, et al. Curso clínico y supervicencia en embolia pulmonar. Resultados del registro multicéntrico colombiano (EMEPCO). Acta Médica Colombiana 2008;33:111-6.

Volschan A, Campos de Albuquerque D, Rangel Tura B, de Freitas Knibel M, Pereira da Silva e Souza P, Toscano M, et al. Pulmonary embolism: multicenter registry in tertiary hospitals. Rev Bras Ter Intensiva 2009;21:237-46.

Consenso de Enfermedad Tromboembólica. Consenso Argentino SAC. Rev Argent Cardiol 2009;77:411-28.

Kucher N, Rossi E, De Rosa M, Godlhaber SZ. Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch Intern Med 2005;165:1777-81.

Jiménez D, de Miguel-Díez J, Guijarro R, Trujillo-Santos J, Otero R, Barba R, et al. Trends in the Management and Outcomes of Acute Pulmonary Embolism. Analysis From the RIETE Registry. J Am Coll Cardiol 2016;67:162-70.

Stein P, Matta F. Thrombolytic Therapy in Unstable Patients with Acute Pulmonary Embolism: Saves Lives but Underused. Am J Med 2012;125:465-70.

Chatterjee S, Chakraborty A, Weinberg I, Kadakia M, Wilensky R, Sardar P, et al. Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial Hemorrhage. A Meta-analysis. JAMA 2014;311:2414-21.

Sculman S, Kearon C, Kakkar A, Mismetti P, Schellong S, Eriks¬son H, et al. Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism. N Engl J Med 2009;361:2342-52. http://

Bauersachs R, Berkowitz S, Brenner B, Büller H, Decousus H, Gallus A, et al. Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism. N Engl J Med 2012;366:1287-97.

Agnelli G, Buller H, Cohen A, Curto M, Gallus A, Johnson M, et al. Oral Apixaban for the Treatment of Acute Venous Thromboembolism. N Engl J Med 2013;369:799-808.

van der Hulle T, Kooiman J, den Exter P, Dekkers O, Klok F, Huis¬man M, et al. Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. J Thromb Haemost 2014;12:320-8.

Full Text


  • There are currently no refbacks.

Licencia Creative Commons
The documents published in this journal are under the licencia Creative Commons Atribución-NoComercial-Compartir-Igual 2.5 Argentina.

Revista argentina de cardiología. ISSN en línea 1850-3748. Argentine journal of cardiology (English ed. Online ISSN 2314-2286) Sociedad Argentina de Cardiología. Azcuénaga 980 (C1115AAD),Ciudad Autónoma de Buenos Aires, República Argentina. Tel. (54 11) 4961-6027/8/9 Fax: 4961-6020